Skip to main content
Clinical Trials/ACTRN12620000838910
ACTRN12620000838910Not yet recruiting未知

Cough suppression therapy as a treatment for acute persistent cough following an upper respiratory tract infection

John Hunter Hospital0 sites101 target enrollmentStarted: August 24, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
101

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 18 years of age or older.
  • Cough between 3 and 6 weeks duration following upper respiratory tract infection
  • Cough severity visual analogue scale>39mm
  • Non-productive cough
  • Probable viral infection as defined by the Common Cold Questionnaire

Exclusion Criteria

  • 1.Primary diagnosis of history of cough secondary to lower airway disease
  • 2.Haemoptysis
  • 3.Productive cough of > 1 table spoon phlegm per day.
  • 4.Cystic fibrosis
  • 5.Bronchiectasis/bronchitis
  • 6.Chronic obstructive pulmonary disease
  • 7.Interstitial lung disease
  • 8.Cognitive impairment, poor English language skills or significant untreated hearing impairment that prevents completion of data collection forms or understanding verbal instructions.
  • 9.Inability to attend study visits.
  • 10.Current smoker or smoker with >20 pack-year smoking history
  • 11.Prominent dyspnoea, especially at rest or at night
  • 12.History of unexplained weight loss
  • 13.Chest pain
  • 14.Current pneumonia
  • 15.Medical concern regarding diagnosis

Investigators

Similar Trials

Cough suppression therapy as a treatment... | Clinical Trial